![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, February 25, 2005 6:44:31 PM
I feel were still VERY much in the mix with Bio... why would we still be on there supervisory board ? The time isnt right for the deal to go threw at this point . Our SP is to low and would kill us at this point . JMO any one else care to take a guess ? Im all ears .PS I wont be able to read any more post tonight .I plan on trying out some Blue goose :P and should slowly slip into a coma for the next 2 days !!! Hopfully Monday will bring us new news from our Co.
Hummer
supervisory board
Prof. Axel Kleemann, PhD, formerly a member of the executive board of ASTA Medica, where he was responsible for R&D, production, engineering, and drug safety (Chairman)
Timo Hercegfi, Partner, Heidelberg Innovation (Vice Chairman)
Richard Gabriel, MS, MBA, CEO and President of DNAPrint genomics Inc., FL, USA
Hector J. Gomez, MD, PhD, Chairman and Chief Medical Officer of DNAPrint genomics Inc., FL, USA
Ulrich Granzer, MD, former head of regulatory affairs at Glaxo Welcome, head of drug registration at BASF Pharma, and Vice President Global Regulatory Affairs at Bayer AG
Prof. Bernd Wetzel, PhD, former head of world-wide research and non-clinical development at Boehringer Ingelheim
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM